Biotech Values

[vinmantoo]

Dew,

I know both of use were big skeptics about DNDN because it was priced to perfection and had a market cap of more than $5 billion despite only limited sales. As far as DNDN ever being profitable, we know a course of Provenge treatment costs $90K, but how much of that is profit/treatment?

DNDN was dramatically scaling up their production facilities before securing solid demand. Looks like that is smacking them in the face a bit now.